BAVA:VIE
Bavarian Nordic
31,92 €
arrow_upward
+1,33%(+0,42) 1 d
15 okt., 17:36:00 GMT+2 · EUR
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för BAVA …
Öppen
31,60 €
Högt
31,92 €
Lågt
31,42 €
Börsvärde
2,83 md
Genomsn. vol.
17,00
Volym
0,00
52v högst
32,47 €
52v lägst
22,96 €
Antal anställda
2 tn
Öppen
31,60 €
Högt
31,92 €
Lågt
31,42 €
Börsvärde
2,83 md
Genomsn. vol.
17,00
Volym
0,00
52v högst
32,47 €
52v lägst
22,96 €
Antal anställda
2 tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
GlobeNewswire
·
för 3 dagar sedan
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
Profil
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
Om Bavarian Nordic